Showing results (31-40 of 60) with videos related to
Sort By:
Pageof 6
The Lancet. Respiratory Medicine|January 17, 2014
Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomised, double-blind, parallel-group studyJadwiga A Wedzicha, Marc Decramer, Joachim H Ficker, et al.Journal of the Academy of Consultation-Liaison Psychiatry|July 1, 2026
Integrated Psychosomatic Care in General Hospital Medicine: An Observational Study of Outcomes in Medically Complex InpatientsPaul Köbler, Hanna Hofmann, Sabine Lange, et al.Anticancer Research|December 1, 2017
Comparison of <i>PD-L1</i> mRNA Expression Measured with the CheckPoint Typer® Assay with PD-L1 Protein Expression Assessed with Immunohistochemistry in Non-small Cell Lung CancerRamona Erber, Robert Stöhr, Stefanie Herlein, et al.Journal of Geriatric Oncology|November 2, 2022
Older patients with EGFR mutation-positive non-small cell lung cancer treated with afatinib in clinical practice: A subset analysis of the non-interventional GIDEON studyWolfgang M Brueckl, Martin Reck, Harald Schäfer, et al.Translational Lung Cancer Research|January 10, 2022
Predictive value of mRNA expression and dynamic changes from immune related biomarkers in liquid biopsies before and after start of pembrolizumab in stage IV non-small cell lung cancer (NSCLC)Natalie F Brueckl, Ralph M Wirtz, Fabian P M Reich, et al.Plos One|October 30, 2016
Systematic Analysis of Self-Reported Comorbidities in Large Cohort Studies - A Novel Stepwise Approach by Evaluation of MedicationTanja Lucke, Ronald Herrera, Margarethe Wacker, et al.The European Respiratory Journal|January 28, 2012
Efficacy predictors of lung volume reduction with Zephyr valves in a European cohortFelix J F Herth, Marc Noppen, Arschang Valipour, et al.International Journal of Oncology|July 24, 2015
The pan-deacetylase inhibitor panobinostat affects angiogenesis in hepatocellular carcinoma models via modulation of CTGF expressionSusanne Gahr, Christian Mayr, Tobias Kiesslich, et al.Respiration; International Review of Thoracic Diseases|August 5, 2021
Endobronchial Valve (Zephyr) Treatment in Homogeneous Emphysema: One-Year Results from the IMPACT Randomized Clinical TrialRalf Eberhardt, Dirk-Jan Slebos, Felix J F Herth, et al.Clinical Medicine Insights. Oncology|September 5, 2020
Efficacy of Docetaxel Plus Ramucirumab as Palliative Third-Line Therapy Following Second-Line Immune-Checkpoint-Inhibitor Treatment in Patients With Non-Small-Cell Lung Cancer Stage IVWolfgang M Brueckl, Martin Reck, Achim Rittmeyer, et al.Pageof 6